1 Market Overview

1.1 Product Overview and Scope of Adoptive Cell Transfer Therapy

1.2 Classification of Adoptive Cell Transfer Therapy by Type

1.2.1 Overview: Global Adoptive Cell Transfer Therapy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Type in 2021

1.2.3 NK

1.2.4 LAK

1.2.5 DC

1.2.6 CIK

1.2.7 CTL

1.2.8 TIL

1.2.9 TCR-T

1.2.10 CAR-T

1.3 Global Adoptive Cell Transfer Therapy Market by Application

1.3.1 Overview: Global Adoptive Cell Transfer Therapy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Acute Lymphocytic Leukemia

1.3.3 NHL

1.3.4 Melanoma

1.3.5 Bladder Cancer

1.3.6 Lung Cancer

1.3.7 Head and Neck Cancer

1.3.8 Multiple Myeloma

1.3.9 Other

1.4 Global Adoptive Cell Transfer Therapy Market Size & Forecast

1.5 Global Adoptive Cell Transfer Therapy Market Size and Forecast by Region

1.5.1 Global Adoptive Cell Transfer Therapy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Adoptive Cell Transfer Therapy Market Size by Region, (2017-2022)

1.5.3 North America Adoptive Cell Transfer Therapy Market Size and Prospect (2017-2028)

1.5.4 Europe Adoptive Cell Transfer Therapy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Adoptive Cell Transfer Therapy Market Size and Prospect (2017-2028)

1.5.6 South America Adoptive Cell Transfer Therapy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Adoptive Cell Transfer Therapy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Adoptive Cell Transfer Therapy Market Drivers

1.6.2 Adoptive Cell Transfer Therapy Market Restraints

1.6.3 Adoptive Cell Transfer Therapy Trends Analysis

2 Company Profiles

2.1 Novartis AG

2.1.1 Novartis AG Details

2.1.2 Novartis AG Major Business

2.1.3 Novartis AG Adoptive Cell Transfer Therapy Product and Solutions

2.1.4 Novartis AG Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Novartis AG Recent Developments and Future Plans

2.2 Kite Pharma

2.2.1 Kite Pharma Details

2.2.2 Kite Pharma Major Business

2.2.3 Kite Pharma Adoptive Cell Transfer Therapy Product and Solutions

2.2.4 Kite Pharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Kite Pharma Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Adoptive Cell Transfer Therapy Product and Solutions

2.3.4 Pfizer Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 Juno Therapeutics

2.4.1 Juno Therapeutics Details

2.4.2 Juno Therapeutics Major Business

2.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

2.4.4 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Juno Therapeutics Recent Developments and Future Plans

2.5 Celgene Corporation

2.5.1 Celgene Corporation Details

2.5.2 Celgene Corporation Major Business

2.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Product and Solutions

2.5.4 Celgene Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Celgene Corporation Recent Developments and Future Plans

2.6 CARsgen Therapeutics

2.6.1 CARsgen Therapeutics Details

2.6.2 CARsgen Therapeutics Major Business

2.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

2.6.4 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 CARsgen Therapeutics Recent Developments and Future Plans

2.7 Sorrento Therapeutics

2.7.1 Sorrento Therapeutics Details

2.7.2 Sorrento Therapeutics Major Business

2.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

2.7.4 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Sorrento Therapeutics Recent Developments and Future Plans

2.8 Legend Biotech

2.8.1 Legend Biotech Details

2.8.2 Legend Biotech Major Business

2.8.3 Legend Biotech Adoptive Cell Transfer Therapy Product and Solutions

2.8.4 Legend Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Legend Biotech Recent Developments and Future Plans

2.9 Atara Biotherapeutics

2.9.1 Atara Biotherapeutics Details

2.9.2 Atara Biotherapeutics Major Business

2.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product and Solutions

2.9.4 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Atara Biotherapeutics Recent Developments and Future Plans

2.10 Aurora Biopharma

2.10.1 Aurora Biopharma Details

2.10.2 Aurora Biopharma Major Business

2.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Product and Solutions

2.10.4 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Aurora Biopharma Recent Developments and Future Plans

2.11 Autolus Therapeutics PLC

2.11.1 Autolus Therapeutics PLC Details

2.11.2 Autolus Therapeutics PLC Major Business

2.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product and Solutions

2.11.4 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Autolus Therapeutics PLC Recent Developments and Future Plans

2.12 Bluebird

2.12.1 Bluebird Details

2.12.2 Bluebird Major Business

2.12.3 Bluebird Adoptive Cell Transfer Therapy Product and Solutions

2.12.4 Bluebird Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Bluebird Recent Developments and Future Plans

2.13 Carina Biotech

2.13.1 Carina Biotech Details

2.13.2 Carina Biotech Major Business

2.13.3 Carina Biotech Adoptive Cell Transfer Therapy Product and Solutions

2.13.4 Carina Biotech Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Carina Biotech Recent Developments and Future Plans

2.14 Athenex

2.14.1 Athenex Details

2.14.2 Athenex Major Business

2.14.3 Athenex Adoptive Cell Transfer Therapy Product and Solutions

2.14.4 Athenex Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Athenex Recent Developments and Future Plans

2.15 Xiangxue Pharmaceutical (Xiangxue Precision)

2.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Details

2.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Major Business

2.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product and Solutions

2.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments and Future Plans

2.16 Hengrui Yuanzheng

2.16.1 Hengrui Yuanzheng Details

2.16.2 Hengrui Yuanzheng Major Business

2.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product and Solutions

2.16.4 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Hengrui Yuanzheng Recent Developments and Future Plans

2.17 Eureka Therapeutics

2.17.1 Eureka Therapeutics Details

2.17.2 Eureka Therapeutics Major Business

2.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

2.17.4 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Eureka Therapeutics Recent Developments and Future Plans

2.18 WuXi Juno

2.18.1 WuXi Juno Details

2.18.2 WuXi Juno Major Business

2.18.3 WuXi Juno Adoptive Cell Transfer Therapy Product and Solutions

2.18.4 WuXi Juno Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 WuXi Juno Recent Developments and Future Plans

2.19 Shenzhen Inno Immunity

2.19.1 Shenzhen Inno Immunity Details

2.19.2 Shenzhen Inno Immunity Major Business

2.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product and Solutions

2.19.4 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Shenzhen Inno Immunity Recent Developments and Future Plans

2.20 Shenzhen Binde Bio

2.20.1 Shenzhen Binde Bio Details

2.20.2 Shenzhen Binde Bio Major Business

2.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product and Solutions

2.20.4 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Shenzhen Binde Bio Recent Developments and Future Plans

2.21 Kerui Bio

2.21.1 Kerui Bio Details

2.21.2 Kerui Bio Major Business

2.21.3 Kerui Bio Adoptive Cell Transfer Therapy Product and Solutions

2.21.4 Kerui Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Kerui Bio Recent Developments and Future Plans

2.22 Adaptimmune

2.22.1 Adaptimmune Details

2.22.2 Adaptimmune Major Business

2.22.3 Adaptimmune Adoptive Cell Transfer Therapy Product and Solutions

2.22.4 Adaptimmune Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 Adaptimmune Recent Developments and Future Plans

2.23 Altor Bioscience Corporation

2.23.1 Altor Bioscience Corporation Details

2.23.2 Altor Bioscience Corporation Major Business

2.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product and Solutions

2.23.4 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.23.5 Altor Bioscience Corporation Recent Developments and Future Plans

2.24 Cellectis

2.24.1 Cellectis Details

2.24.2 Cellectis Major Business

2.24.3 Cellectis Adoptive Cell Transfer Therapy Product and Solutions

2.24.4 Cellectis Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.24.5 Cellectis Recent Developments and Future Plans

2.25 Takara Bio

2.25.1 Takara Bio Details

2.25.2 Takara Bio Major Business

2.25.3 Takara Bio Adoptive Cell Transfer Therapy Product and Solutions

2.25.4 Takara Bio Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.25.5 Takara Bio Recent Developments and Future Plans

2.26 Unum Therapeutics

2.26.1 Unum Therapeutics Details

2.26.2 Unum Therapeutics Major Business

2.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

2.26.4 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.26.5 Unum Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Adoptive Cell Transfer Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Adoptive Cell Transfer Therapy Players Market Share in 2021

3.2.2 Top 10 Adoptive Cell Transfer Therapy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Adoptive Cell Transfer Therapy Players Head Office, Products and Services Provided

3.4 Adoptive Cell Transfer Therapy Mergers & Acquisitions

3.5 Adoptive Cell Transfer Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Adoptive Cell Transfer Therapy Revenue and Market Share by Type (2017-2022)

4.2 Global Adoptive Cell Transfer Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2017-2022)

5.2 Global Adoptive Cell Transfer Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Adoptive Cell Transfer Therapy Revenue by Type (2017-2028)

6.2 North America Adoptive Cell Transfer Therapy Revenue by Application (2017-2028)

6.3 North America Adoptive Cell Transfer Therapy Market Size by Country

6.3.1 North America Adoptive Cell Transfer Therapy Revenue by Country (2017-2028)

6.3.2 United States Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

6.3.3 Canada Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

6.3.4 Mexico Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Adoptive Cell Transfer Therapy Revenue by Type (2017-2028)

7.2 Europe Adoptive Cell Transfer Therapy Revenue by Application (2017-2028)

7.3 Europe Adoptive Cell Transfer Therapy Market Size by Country

7.3.1 Europe Adoptive Cell Transfer Therapy Revenue by Country (2017-2028)

7.3.2 Germany Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

7.3.3 France Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

7.3.5 Russia Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

7.3.6 Italy Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Type (2017-2028)

8.2 Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Application (2017-2028)

8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region

8.3.1 Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Region (2017-2028)

8.3.2 China Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

8.3.3 Japan Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

8.3.4 South Korea Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

8.3.5 India Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

8.3.7 Australia Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Adoptive Cell Transfer Therapy Revenue by Type (2017-2028)

9.2 South America Adoptive Cell Transfer Therapy Revenue by Application (2017-2028)

9.3 South America Adoptive Cell Transfer Therapy Market Size by Country

9.3.1 South America Adoptive Cell Transfer Therapy Revenue by Country (2017-2028)

9.3.2 Brazil Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

9.3.3 Argentina Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Type (2017-2028)

10.2 Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Application (2017-2028)

10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country

10.3.1 Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Country (2017-2028)

10.3.2 Turkey Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

10.3.4 UAE Adoptive Cell Transfer Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Adoptive Cell Transfer Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Adoptive Cell Transfer Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Adoptive Cell Transfer Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Adoptive Cell Transfer Therapy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Adoptive Cell Transfer Therapy Revenue Market Share by Region (2023-2028)

Table 6. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 7. Novartis AG Major Business

Table 8. Novartis AG Adoptive Cell Transfer Therapy Product and Solutions

Table 9. Novartis AG Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Kite Pharma Corporate Information, Head Office, and Major Competitors

Table 11. Kite Pharma Major Business

Table 12. Kite Pharma Adoptive Cell Transfer Therapy Product and Solutions

Table 13. Kite Pharma Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Adoptive Cell Transfer Therapy Product and Solutions

Table 17. Pfizer Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Juno Therapeutics Corporate Information, Head Office, and Major Competitors

Table 19. Juno Therapeutics Major Business

Table 20. Juno Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

Table 21. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Celgene Corporation Corporate Information, Head Office, and Major Competitors

Table 23. Celgene Corporation Major Business

Table 24. Celgene Corporation Adoptive Cell Transfer Therapy Product and Solutions

Table 25. Celgene Corporation Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. CARsgen Therapeutics Corporate Information, Head Office, and Major Competitors

Table 27. CARsgen Therapeutics Major Business

Table 28. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

Table 29. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Sorrento Therapeutics Major Business

Table 32. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

Table 33. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Legend Biotech Corporate Information, Head Office, and Major Competitors

Table 35. Legend Biotech Major Business

Table 36. Legend Biotech Adoptive Cell Transfer Therapy Product and Solutions

Table 37. Legend Biotech Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Atara Biotherapeutics Corporate Information, Head Office, and Major Competitors

Table 39. Atara Biotherapeutics Major Business

Table 40. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product and Solutions

Table 41. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Aurora Biopharma Corporate Information, Head Office, and Major Competitors

Table 43. Aurora Biopharma Major Business

Table 44. Aurora Biopharma Adoptive Cell Transfer Therapy Product and Solutions

Table 45. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Autolus Therapeutics PLC Corporate Information, Head Office, and Major Competitors

Table 47. Autolus Therapeutics PLC Major Business

Table 48. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product and Solutions

Table 49. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Bluebird Corporate Information, Head Office, and Major Competitors

Table 51. Bluebird Major Business

Table 52. Bluebird Adoptive Cell Transfer Therapy Product and Solutions

Table 53. Bluebird Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Carina Biotech Corporate Information, Head Office, and Major Competitors

Table 55. Carina Biotech Major Business

Table 56. Carina Biotech Adoptive Cell Transfer Therapy Product and Solutions

Table 57. Carina Biotech Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Athenex Corporate Information, Head Office, and Major Competitors

Table 59. Athenex Major Business

Table 60. Athenex Adoptive Cell Transfer Therapy Product and Solutions

Table 61. Athenex Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Xiangxue Pharmaceutical (Xiangxue Precision) Corporate Information, Head Office, and Major Competitors

Table 63. Xiangxue Pharmaceutical (Xiangxue Precision) Major Business

Table 64. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product and Solutions

Table 65. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Hengrui Yuanzheng Corporate Information, Head Office, and Major Competitors

Table 67. Hengrui Yuanzheng Major Business

Table 68. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product and Solutions

Table 69. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Eureka Therapeutics Corporate Information, Head Office, and Major Competitors

Table 71. Eureka Therapeutics Major Business

Table 72. Eureka Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

Table 73. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. WuXi Juno Corporate Information, Head Office, and Major Competitors

Table 75. WuXi Juno Major Business

Table 76. WuXi Juno Adoptive Cell Transfer Therapy Product and Solutions

Table 77. WuXi Juno Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Shenzhen Inno Immunity Corporate Information, Head Office, and Major Competitors

Table 79. Shenzhen Inno Immunity Major Business

Table 80. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product and Solutions

Table 81. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Shenzhen Binde Bio Corporate Information, Head Office, and Major Competitors

Table 83. Shenzhen Binde Bio Major Business

Table 84. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product and Solutions

Table 85. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Kerui Bio Corporate Information, Head Office, and Major Competitors

Table 87. Kerui Bio Major Business

Table 88. Kerui Bio Adoptive Cell Transfer Therapy Product and Solutions

Table 89. Kerui Bio Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Adaptimmune Corporate Information, Head Office, and Major Competitors

Table 91. Adaptimmune Major Business

Table 92. Adaptimmune Adoptive Cell Transfer Therapy Product and Solutions

Table 93. Adaptimmune Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Altor Bioscience Corporation Corporate Information, Head Office, and Major Competitors

Table 95. Altor Bioscience Corporation Major Business

Table 96. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product and Solutions

Table 97. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 98. Cellectis Corporate Information, Head Office, and Major Competitors

Table 99. Cellectis Major Business

Table 100. Cellectis Adoptive Cell Transfer Therapy Product and Solutions

Table 101. Cellectis Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 102. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 103. Takara Bio Major Business

Table 104. Takara Bio Adoptive Cell Transfer Therapy Product and Solutions

Table 105. Takara Bio Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 106. Unum Therapeutics Corporate Information, Head Office, and Major Competitors

Table 107. Unum Therapeutics Major Business

Table 108. Unum Therapeutics Adoptive Cell Transfer Therapy Product and Solutions

Table 109. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 110. Global Adoptive Cell Transfer Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 111. Global Adoptive Cell Transfer Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 112. Breakdown of Adoptive Cell Transfer Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 113. Adoptive Cell Transfer Therapy Players Head Office, Products and Services Provided

Table 114. Adoptive Cell Transfer Therapy Mergers & Acquisitions in the Past Five Years

Table 115. Adoptive Cell Transfer Therapy New Entrants and Expansion Plans

Table 116. Global Adoptive Cell Transfer Therapy Revenue (USD Million) by Type (2017-2022)

Table 117. Global Adoptive Cell Transfer Therapy Revenue Share by Type (2017-2022)

Table 118. Global Adoptive Cell Transfer Therapy Revenue Forecast by Type (2023-2028)

Table 119. Global Adoptive Cell Transfer Therapy Revenue by Application (2017-2022)

Table 120. Global Adoptive Cell Transfer Therapy Revenue Forecast by Application (2023-2028)

Table 121. North America Adoptive Cell Transfer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 122. North America Adoptive Cell Transfer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 123. North America Adoptive Cell Transfer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 124. North America Adoptive Cell Transfer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 125. North America Adoptive Cell Transfer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 126. North America Adoptive Cell Transfer Therapy Revenue by Country (2023-2028) & (USD Million)

Table 127. Europe Adoptive Cell Transfer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 128. Europe Adoptive Cell Transfer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 129. Europe Adoptive Cell Transfer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 130. Europe Adoptive Cell Transfer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 131. Europe Adoptive Cell Transfer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 132. Europe Adoptive Cell Transfer Therapy Revenue by Country (2023-2028) & (USD Million)

Table 133. Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 134. Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 135. Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 136. Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 137. Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Region (2017-2022) & (USD Million)

Table 138. Asia-Pacific Adoptive Cell Transfer Therapy Revenue by Region (2023-2028) & (USD Million)

Table 139. South America Adoptive Cell Transfer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 140. South America Adoptive Cell Transfer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 141. South America Adoptive Cell Transfer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 142. South America Adoptive Cell Transfer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 143. South America Adoptive Cell Transfer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 144. South America Adoptive Cell Transfer Therapy Revenue by Country (2023-2028) & (USD Million)

Table 145. Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 146. Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 147. Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 148. Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 149. Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 150. Middle East & Africa Adoptive Cell Transfer Therapy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Adoptive Cell Transfer Therapy Picture

Figure 2. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type in 2021

Figure 3. NK

Figure 4. LAK

Figure 5. DC

Figure 6. CIK

Figure 7. CTL

Figure 8. TIL

Figure 9. TCR-T

Figure 10. CAR-T

Figure 11. Adoptive Cell Transfer Therapy Revenue Market Share by Application in 2021

Figure 12. Acute Lymphocytic Leukemia Picture

Figure 13. NHL Picture

Figure 14. Melanoma Picture

Figure 15. Bladder Cancer Picture

Figure 16. Lung Cancer Picture

Figure 17. Head and Neck Cancer Picture

Figure 18. Multiple Myeloma Picture

Figure 19. Other Picture

Figure 20. Global Adoptive Cell Transfer Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 21. Global Adoptive Cell Transfer Therapy Revenue and Forecast (2017-2028) & (USD Million)

Figure 22. Global Adoptive Cell Transfer Therapy Revenue Market Share by Region (2017-2028)

Figure 23. Global Adoptive Cell Transfer Therapy Revenue Market Share by Region in 2021

Figure 24. North America Adoptive Cell Transfer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 25. Europe Adoptive Cell Transfer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 26. Asia-Pacific Adoptive Cell Transfer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 27. South America Adoptive Cell Transfer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 28. Middle East and Africa Adoptive Cell Transfer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 29. Adoptive Cell Transfer Therapy Market Drivers

Figure 30. Adoptive Cell Transfer Therapy Market Restraints

Figure 31. Adoptive Cell Transfer Therapy Market Trends

Figure 32. Novartis AG Recent Developments and Future Plans

Figure 33. Kite Pharma Recent Developments and Future Plans

Figure 34. Pfizer Recent Developments and Future Plans

Figure 35. Juno Therapeutics Recent Developments and Future Plans

Figure 36. Celgene Corporation Recent Developments and Future Plans

Figure 37. CARsgen Therapeutics Recent Developments and Future Plans

Figure 38. Sorrento Therapeutics Recent Developments and Future Plans

Figure 39. Legend Biotech Recent Developments and Future Plans

Figure 40. Atara Biotherapeutics Recent Developments and Future Plans

Figure 41. Aurora Biopharma Recent Developments and Future Plans

Figure 42. Autolus Therapeutics PLC Recent Developments and Future Plans

Figure 43. Bluebird Recent Developments and Future Plans

Figure 44. Carina Biotech Recent Developments and Future Plans

Figure 45. Athenex Recent Developments and Future Plans

Figure 46. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments and Future Plans

Figure 47. Hengrui Yuanzheng Recent Developments and Future Plans

Figure 48. Eureka Therapeutics Recent Developments and Future Plans

Figure 49. WuXi Juno Recent Developments and Future Plans

Figure 50. Shenzhen Inno Immunity Recent Developments and Future Plans

Figure 51. Shenzhen Binde Bio Recent Developments and Future Plans

Figure 52. Kerui Bio Recent Developments and Future Plans

Figure 53. Adaptimmune Recent Developments and Future Plans

Figure 54. Altor Bioscience Corporation Recent Developments and Future Plans

Figure 55. Cellectis Recent Developments and Future Plans

Figure 56. Takara Bio Recent Developments and Future Plans

Figure 57. Unum Therapeutics Recent Developments and Future Plans

Figure 58. Global Adoptive Cell Transfer Therapy Revenue Share by Players in 2021

Figure 59. Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 60. Global Top 3 Players Adoptive Cell Transfer Therapy Revenue Market Share in 2021

Figure 61. Global Top 10 Players Adoptive Cell Transfer Therapy Revenue Market Share in 2021

Figure 62. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 63. Global Adoptive Cell Transfer Therapy Revenue Share by Type in 2021

Figure 64. Global Adoptive Cell Transfer Therapy Market Share Forecast by Type (2023-2028)

Figure 65. Global Adoptive Cell Transfer Therapy Revenue Share by Application in 2021

Figure 66. Global Adoptive Cell Transfer Therapy Market Share Forecast by Application (2023-2028)

Figure 67. North America Adoptive Cell Transfer Therapy Sales Market Share by Type (2017-2028)

Figure 68. North America Adoptive Cell Transfer Therapy Sales Market Share by Application (2017-2028)

Figure 69. North America Adoptive Cell Transfer Therapy Revenue Market Share by Country (2017-2028)

Figure 70. United States Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Canada Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Mexico Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Europe Adoptive Cell Transfer Therapy Sales Market Share by Type (2017-2028)

Figure 74. Europe Adoptive Cell Transfer Therapy Sales Market Share by Application (2017-2028)

Figure 75. Europe Adoptive Cell Transfer Therapy Revenue Market Share by Country (2017-2028)

Figure 76. Germany Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. France Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. United Kingdom Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Russia Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Italy Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Asia-Pacific Adoptive Cell Transfer Therapy Sales Market Share by Type (2017-2028)

Figure 82. Asia-Pacific Adoptive Cell Transfer Therapy Sales Market Share by Application (2017-2028)

Figure 83. Asia-Pacific Adoptive Cell Transfer Therapy Revenue Market Share by Region (2017-2028)

Figure 84. China Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Japan Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. South Korea Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. India Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. Southeast Asia Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Australia Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 90. South America Adoptive Cell Transfer Therapy Sales Market Share by Type (2017-2028)

Figure 91. South America Adoptive Cell Transfer Therapy Sales Market Share by Application (2017-2028)

Figure 92. South America Adoptive Cell Transfer Therapy Revenue Market Share by Country (2017-2028)

Figure 93. Brazil Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 94. Argentina Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 95. Middle East and Africa Adoptive Cell Transfer Therapy Sales Market Share by Type (2017-2028)

Figure 96. Middle East and Africa Adoptive Cell Transfer Therapy Sales Market Share by Application (2017-2028)

Figure 97. Middle East and Africa Adoptive Cell Transfer Therapy Revenue Market Share by Country (2017-2028)

Figure 98. Turkey Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 99. Saudi Arabia Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 100. UAE Adoptive Cell Transfer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 101. Methodology

Figure 102. Research Process and Data Source